Home > about TAEJOON > CEO
01. Production quality and the personnel
02. Building and Facilities
03. Equipment
04. Ingredients and Container, Wrapping material control
05. Producing and Processing control
06. Wrapping and Labeling Control
07. Charging and Delivering
08. Laboratory Control
09. Recording and Reporting
10. Returning and Treating Fault Storage Products
Check an applied medicine is being produced according to the cGMP standards in the process of applying sales license of the specific medicine inside America
FDA inspectors examine whether necessary facilities, equipments, and skill of the applied producer conform to the cGMP standards.
The conformity to cGMP standards is judged on the basis of the result of inspection on the facilities, analyzing the samples, and the cGMP operation record history.
If the plant does not conform to the cGMP standards, warning can be led and this can be leaded to the disapproval of Medicine.
Completion of the Taejoon Plant 1
X-Ray Contrast media introduced 5th in the world, first in Korea
Antacids & antiulcerants LANIMA-G introduced


Enlargement of Teajoon plant completed
Obtains a sanction for establishing central research institute attached to the company
Approved as the company No. 89 that meets the kGMP standars (Ministry of Health and Welfare)
Featured on TV(KBS 1) and Newspaper as the successful company for innovating factory
Achieves localization of Contrast Media for Angiography
Exports TAEJOON SOLOTOP to Southeast Asia
Awarded Industry Peace Grand Prize (Yongin city)
Appointed as Promising Small Business Company (Kyonggi Province)
Sets up a Management Information System (MIS)
Liquid Drug (Extender) gets KGMP approval gets kGMP approval
Awarded a Venture Company Grand Prize with localizing the contrast media for Angiography
Appointed as Venture company of producing advanced medicines (Seoul Regional Office Small & Medium Business Administration)
Makes the record of achieving Undisaster 5 times (Korea Occupational Safety & Health Agency)
Participates in RSNA (Radiology society of North America)
The ceremony of laying the cornerstone of plant according to cGMP guideline Expects to complete the cGMP-level Plant.
Ranked in a good place in GMP evaluation by Korean FDA
Successfully inspected by European authority for Xalost ophthalmic solution

Injection, ophthalmic solution, ophthalmic ointment
Tablet, Capsule, Granule, Power, Drysyrup
Liquid (Suspension, Syrup)